Taiho Oncology Announces Decitabine and Cedazuridine to be Included in NIH Precision Medicine Trials
Hand-out
Press Releases
January 14, 2025

Taiho Oncology Announces Decitabine and Cedazuridine to be Included in NIH Precision Medicine Trials

Drug combination part of next-generation trials targeting specific genetic mutations in patients with myelodysplastic syndromes and acute myeloid leukemia

bradford

The Bradford Era

Local & Social